AmbAgon Therapeutics
Netherlands - Eindhoven
BiotechnologyFocus: Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins
AmbAgon Therapeutics is a life sciences company focused on Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Oncology
Funding Stage
PUBLIC
Open Jobs
0
Open Jobs (0)
No open positions listed yet. Check their careers page directly.